Kristen Fortney, cofounder and CEO of BioAge Labs. From the San Francisco Business Times. BioAge Labs Inc., which has turned its aging diseases focus toward the hot area of obesity drugs ...

BioAge Labs (NASDAQ:BIOA) shares rallied nearly 30% Thursday after the obesity drug developer made its market debut through ...

Obesity-drug developer BioAge Labs Inc. held on to a slim gain at the closing bell and natural-gas producer BKV Corp. ended flat Thursday, the day the two initial public offerings debuted.

“Our skin has built-in receptors for Vitamin C” says Dr Sturnham, which is why it is key to ensure we get our daily skincare fix of it. Vitamin C has many benefits such as improving skin ...

The skincare section provides you with articles on various topics that deal with skin problems and their solutions ... 5 red fruits are rich in vitamin C and antioxidants. They can stabilize ...

RICHMOND, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases ...

Empowering the future of aging research: BioAge to sponsor ARDD 2024, the world's largest conference on aging research in the biopharmaceutical industry Disclaimer: AAAS and EurekAlert!

Jefferies initiated coverage of BioAge Labs (BIOA) with a Buy rating and $42 price target BioAge is a clinical stage biotech focusing on metabolic diseases, the analyst tells investors in a ...

Most teenagers in puberty tend to suffer from skincare woes, including uneven skin tone and acne. Before rushing to put your ...

BioAge Labs (BIOA) announced that it will present new preclinical data for its lead product candidate azelaprag, an orally available small molecule agonist of the apelin receptor APJ. The data ...

BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. BioAge’s lead ...